Visaka Industries has secured a significant legal victory as the Supreme Court of India dismissed a Special Leave Petition (SLP) filed by the Hyderabad Cricket Association (HCA). This ruling upholds an arbitration award in favor of Visaka Industries, entitling the company to receive ₹25.92 crores plus interest.

Legal Battle Background

The dispute between Visaka Industries and the Hyderabad Cricket Association dates back to 2004, involving an agreement for naming rights and advertisement rights of an International Cricket Stadium in Hyderabad. The legal journey has been extensive:

1. An arbitration award was passed in favor of Visaka Industries on March 15, 2016.
2. HCA challenged this award in the Commercial Court, Hyderabad, which was dismissed on July 19, 2024.
3. HCA then appealed to the Telangana High Court, which was dismissed on June 25, 2025.
4. Finally, HCA filed an SLP in the Supreme Court, which has now been dismissed on October 6, 2025.

Financial Implications

The dismissal of HCA's appeal by the Supreme Court marks a significant milestone for Visaka Industries. Here's what it means for the company:

What's Next for Visaka Industries

With the legal hurdles cleared, Visaka Industries is now poised to take steps to enforce the arbitration award. The company's management expects this outcome to have a positive impact on its financials.

Market Reaction

Investors and market analysts will be closely watching how this legal victory translates into tangible financial gains for Visaka Industries. The influx of ₹25.92 crores plus interest could potentially strengthen the company's financial position.

Conclusion

This legal victory for Visaka Industries underscores the importance of perseverance in corporate legal battles. As the company moves to enforce the arbitration award, stakeholders will be keen to see how this financial windfall is utilized to drive growth and create value for shareholders.

Visaka Industries Limited has announced a significant addition to its leadership team, appointing Dr. Gaddam Vritika as Chief Business Strategist and Advisor to the Chairman. The appointment, set to take effect on April 1, 2025, was approved by the company's Board of Directors on March 26, 2025, following a recommendation from the Nomination and Remuneration Committee.

New Role and Responsibilities

Dr. Vritika, 37, will step into the dual role of Chief Business Strategist and Advisor to the Chairman, bringing her unique blend of medical expertise and entrepreneurial acumen to Visaka Industries. While specific details of her responsibilities have not been disclosed, her position suggests she will play a crucial role in shaping the company's strategic direction and advising on key business decisions.

Professional Background

Dr. Gaddam Vritika comes to Visaka Industries with an impressive background in medicine and entrepreneurship:

Additionally, she is the co-founder of NAVA Skin and Body Clinic, demonstrating her entrepreneurial skills.

Her combination of medical knowledge and business experience positions her well for a strategic role in a diversified company like Visaka Industries.

Family Ties and Corporate Governance

The appointment of Dr. Vritika highlights the strong family involvement in Visaka Industries' leadership:

• Daughter of Chairman Dr. G. Vivek Venkatswamy and Managing Director Smt. G. Saroja Vivekanand
• Sister of Joint Managing Director Shri G. Vamsi Krishna

While family-led businesses are not uncommon in India, this appointment may draw attention to the company's corporate governance practices and succession planning strategies.

Implications for Visaka Industries

The addition of Dr. Vritika to the executive team could signal Visaka Industries' intent to:

1. Bring fresh perspectives to its business strategy
2. Potentially explore new markets or product lines, possibly leveraging her medical background
3. Strengthen its leadership pipeline with next-generation family members

As Visaka Industries prepares for this transition, stakeholders will likely be watching closely to see how Dr. Vritika's appointment influences the company's strategic direction and performance in the coming years.